{
  "id": 8233338,
  "title": "Lisata deal propels Marea’s drug pipeline to Wall Street",
  "url": "https://urgent.news/2026/09/17/lisata-deal-propels-mareas-drug-pipeline-to-wall-street",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-17T21:39:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/lisata-marea-deal-acquire-cardiovascular-endocrine-disease-drugs/830717/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Marea’s acquisition by Lisata, alongside a $225 million financing deal, will back development of a pair of medicines in mid-stage testing for cardiovascular and endocrine conditions.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}